Medicaid expansion was associated with higher survival rates among women with breast cancer, according to a 2026 study published in JAMA Network. These effects differed across racial and ethnic groups, with Latina women benefiting the most and Black women continuing to face excess mortality despite overall gains in survival. This is just one of several recent studies linking Medicaid expansion with improved outcomes for people with various cancers.
“These complementary findings suggest that Medicaid expansion is associated with improved survival through multiple pathways, by facilitating timely detection, enabling treatment initiation and reducing delays in care, underscoring the layered mechanisms through which policy interventions shape cancer outcomes,” wrote the study’s authors.
In 2014, the Affordable Care Act’s Medicaid expansion granted coverage to adults with incomes up to 138% of the federal poverty level. An earlier Supreme Court ruling prevented nationwide implementation and made the expansion optional for states. Today, all but 10 states have adopted the expansion, according to KFF.
Prior research has focused on the health impacts of Medicaid expansion, showing increased cancer screening prevalence, early-stage diagnosis and improved short-term survival. A study from 2025 linked expanded Medicaid to increased cancer survival, especially in rural and high-poverty areas. The study, published in Cancer Discovery, examined health outcomes across various types of cancer five years after diagnosis.
The latest study is the first to examine the effect of Medicaid expansion on breast cancer survival outcomes seven years after diagnosis.
The 2026 hospital-based cohort study used National Cancer Database data on over 1.5 million women ages 40 to 64 who were diagnosed with breast cancer between 2006 and 2021 to compare survival rates among them before and after Medicaid expansion became available in their state. The women varied by insurance coverage, race, ethnicity, cancer stage, neighborhood income and educational level.
Overall, the researchers found that Medicaid expansion was associated with better survival of breast cancer across disease stage, race and ethnicity, income and type of treatment. Latina women, those with advanced-stage cancer and residents of higher-income neighborhoods benefited the most, while African American women showed only small improvements in survival.
“These findings highlight population-wide benefits while underscoring persistent inequities; policies that pair coverage expansion with targeted efforts to improve timely diagnosis, treatment access and adherence may be needed to close these gaps,” wrote the study’s authors.
For more information on the effects of Medicaid expansion, click #Medicaid and #Health Insurance. You’ll find stories such as:
- “Medicaid Expansion Improves Cancer Survival Among People in Rural and High-Poverty Communities,”
- “Medicaid Expansion Linked to Improved Long-term Survival in Cancer Patients,”
- “Medicaid Expansion Increased Early-Stage Cancer Diagnosis and Survival for Adults 65 and Older” and
- “Medicaid Expansion Associated with Smaller Declines in Early Stage Cancer Diagnoses During Pandemic in U.S.”
Comments
Comments